Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

4.8%

3 terminated/withdrawn out of 62 trials

Success Rate

94.5%

+8.0% vs industry average

Late-Stage Pipeline

39%

24 trials in Phase 3/4

Results Transparency

2%

1 of 52 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
22(39.3%)
N/A
20(35.7%)
Phase 2
6(10.7%)
Phase 1
6(10.7%)
Phase 3
2(3.6%)
56Total
Phase 4(22)
N/A(20)
Phase 2(6)
Phase 1(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (62)

Showing 20 of 62 trials
NCT03633201Not ApplicableActive Not Recruiting

Anatomic Congruent Prosthetic Knee Design

Role: collaborator

NCT04714047Not ApplicableCompleted

Progressive Resistance Training Compared to Neuromuscular Exercise in Patients With Hip Osteoarthritis

Role: collaborator

NCT06019026Not ApplicableCompleted

Five-year Migration Pattern and Bone Mineral Density for the Tri-Lock and Summit Femoral Stems.

Role: lead

NCT05165823Not ApplicableCompleted

The Significance of Sodium Balance and the Value of Salt-blood Test in Identifying Salt Sensitive Patients

Role: lead

NCT02384668Not ApplicableCompleted

D-vitamin And Graves' Disease; Morbidity And Relapse Reduction

Role: collaborator

NCT03996382Not ApplicableCompleted

Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome

Role: collaborator

NCT01515670Completed

Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA)

Role: collaborator

NCT03431753Not ApplicableUnknown

Early and Accurate Detection of Prostate Cancer in General Practice

Role: collaborator

NCT04363554Not ApplicableCompleted

The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease

Role: lead

NCT04363567Completed

Endothelial Glycocalyx in Patients With Chronic Kidney Disease

Role: lead

NCT01554748Not ApplicableUnknown

Improvement of Implant Survival in Total Joint Arthroplasty of the Trapeziometacarpal Joint

Role: lead

NCT03434600Not ApplicableCompleted

Comparison of Oxford UKA and Sigma UKA With RSA.

Role: lead

NCT03868800Not ApplicableCompleted

Shared Decision-Making and Dialysis Choice

Role: collaborator

NCT03803124Phase 3Completed

Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD

Role: lead

NCT02527863Phase 2Completed

Effect of the Aquaretic Tolvaptan on Nitric Oxide System

Role: lead

NCT02078973Phase 2Completed

Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)

Role: lead

NCT01459900Not ApplicableCompleted

Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial

Role: collaborator

NCT01762488Phase 3Terminated

Renal Denervation in Treatment Resistant Hypertension

Role: collaborator

NCT00298753Phase 4Withdrawn

Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine

Role: lead

NCT00439023Phase 4Completed

Glucose in Dialysis Water in Non-diabetics

Role: lead